
|Articles|January 25, 2008
Once-daily amoxicillin approved
Moxatag is the name of a new once-daily amoxicillin product for pharyngitis and tonsillitis following strep throat
Advertisement
MiddleBrook Pharmaceuticals' Moxatag (amoxicillin extended-release) Tablets 775 mg have been approved to treat adults and children 12 and older with pharyngitis and/or tonsillitis secondary to strep throat. The Germantown, Md., firm claims that its product is the first once-daily amoxicillin product approved in this country. Its convenient dosing should ensure better drug compliance.
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5







































